Mankind Pharma forays into diagnostics
Mankind Pharma is foraying into diagnostics
space with its new venture, Pathkind Diagnostics, for which it plans to
invest Rs 305 crore over a four-year period. As a part of the strategy,
Pathkind would aim to reach out to the masses in tier 2/3 cities in India to
provide easily accessible high- quality diagnostics services at affordable
prices.
The company plans to open 12 large labs, 20
rapid response labs and 150 collection centres in 12 months, and will operate
on a three-tier model With a reference lab in Gurgaon, it will also have
multiple collection centers in small towns and villages, which will be
connected through the network of labs. Initially, the company will start its
operations from Uttar Pradesh and move to Uttarakhand.
Comments
Post a Comment